ACG 2022 Annual Scientific Meeting

Join GI physicians from the U.S. and around the world for the ACG Annual Scientific Meeting. ACG 2022 will deliver the latest clinical information on timely topics in gastroenterology and hepatology.

Monday, October 24, 2022 | ALL TIMES ARE LISTED IN THE EASTERN TIME ZONE
7:50 am Opening Remarks
Samir A. Shah, MD, FACG, ACG President
8:00 am Presidential Plenary Session 1
Moderators: Samir A. Shah, MD, FACG and Brooks D. Cash, MD, FACG
9:00 am President's Address
Samir A. Shah, MD, FACG, ACG President
Introduced by: Daniel J. Pambianco, MD, FACG, ACG President-Elect
9:30 am Presidential Plenary Session 2
Moderators: Daniel J. Pambianco, MD, FACG and Brooks D. Cash, MD, FACG
10:00 am Scientific Poster Session B Opens (10:00 am – 12:00 pm)
10:00 am Exhibit Hall Opens
10:15 am Hands-On Endoscopy Workshop Center Opens
10:30 am Break – Visit the Exhibit Hall / Browse Scientific Posters
10:30 am Exhibitor Theater
10:30 am Scientific Poster Session B – Authors Present (until 11:30 am)
11:30 am Simultaneous Symposia:
In-person attendees will have the opportunity to attend the symposium of their choice in Charlotte. ACG will livestream one of the symposia for virtual attendees; the other symposia will be recorded and available on the Conference Platform as ondemand videos after the meeting.

Symposium 1A: IBD Partners in Crime: Management of Concurrent Conditions

Moderator: Arun C. Swaminath, MD, FACG

  • IBD and Infections: Stop Everything or No Big Deal?
    Arun C. Swaminath, MD, FACG
    Highlight common bacterial, viral (COVID), and fungal infections in IBD patients and explore ways to address ongoing immunosuppressive therapies during treatment.
  • IBD and IBS
    Ruby C. Greywoode, MD
    Differentiate between inflammatory versus functional symptoms and review multidisciplinary management strategies.
  • IBD and Malignancy: Management of Remote, Recent, and Concurrent Malignancy
    Jordan E. Axelrad, MD, MPH
    Summarize the best data on management of biologics and small molecules in patients with remote, recent, and concurrent malignancy.

Symposium 1B: Past Presidents’ Symposium
Moderator: Mark B. Pochapin, MD, FACG

  • Detection and Prevention of Colorectal Cancer
    Past President: Carol A. Burke, MD, FACG
    Harminder Singh, MD, FACG
    Appraise and apply contemporary evidence in the management of hereditary colorectal cancer syndromes.
  • Preventing Neoplastic Progression in Ulcerative Colitis
    Past President: Stephen B. Hanauer, MD, MACG
    Thomas A. Ullman, MD, FACG
    Recognize evolving techniques to prevent neoplastic progression in UC.
  • Epigenetics and the Development of Non-Alcoholic Fatty Liver Disease
    Past President: Rowen K. Zetterman, MD, MACG
    Cynthia A. Moylan, MD, MHS
    Discuss epigenetics and the development of nonalcoholic fatty liver disease.
  • Update in Liver Transplantation: Implications for the GI Provider
    Norah A. Terrault, MD, MPH, FACG
    Summarize new UNOS policies governing organ allocation for liver transplantation, and outline evidence-based recommendations for the general gastroenterologist caring for patients both pre- and post-transplantation.
  • Current Concepts in the Management of Hepatic Encephalopathy
    R. Todd Frederick, MD
    Review current and evolving guidelines for the diagnosis and management of occult and overt hepatic encephalopathy.

Symposium 1C: The Changing Landscape in the Management of Esophageal Disorders
Moderator: Rena Yadlapati, MD

  • Non-Achalasia Motility Disorders: Treatment Highlights
    Rena Yadlapati, MD
    Summarize the updated Chicago Classification v4.0 for motility disorders and discuss treatment options.
  • EoE: What’s New? Diet, Drugs, and Beyond
    Kristle Lynch, MD
    Explain EoE management strategies with current and upcoming pharmacologic agents, specialized diets, and dilation.
  • GERD: Updates in the Diagnostic Criteria and Novel Therapies
    Felice Schnoll-Sussman, MD
    Explore the most recent diagnostic guidelines and summarize therapeutic modalities for GERD.
12:45 pm Lunch Break – Visit the Exhibit Hall
12:45 pm Exhibitor Theater
1:40 pm Exhibitor Theater
2:15 pm Simultaneous Plenary Sessions 1A and 1B
3:00 pm Scientific Poster Session C Opens (3:00 pm – 5:00 pm)
3:05 pm The American Journal of Gastroenterology Lecture
Introduced by: Jasmohan Bajaj, MD, MS, FACG, and Millie D. Long, MD, MPH, FACG

The Transformative Power of Research Carried Out by Busy Clinicians
Patrick S. Kamath, MD
Explain how clinicians can participate in research that moves the fields of gastroenterology and hepatology forward.
3:35 pm Break – Visit the Exhibit Hall / Browse Scientific Posters
3:45 pm Exhibitor Theater
3:45 pm Scientific Poster Session C – Authors Present (until 4:45 pm)
4:00 pm How to Get Published: ACG Journal Editors' Roundtable
Brian E. Lacy, MD, PhD, FACG, Brennan M. Spiegel, MD, MSHS, FACG, and Brian C. Jacobson, MD, MPH
4:45 pm Simultaneous Symposia: Session 2
In-person attendees will have the opportunity to attend the symposium of their choice in Charlotte. ACG will livestream one of the symposia for virtual attendees; the other symposia will be recorded and available on the Conference Platform as ondemand videos after the meeting.

Symposium 2A: Common Liver Consults
Moderator: Joseph Ahn, MD, MS, MBA, FACG

  • Approach to Focal Liver Lesions
    Joseph Ahn, MD, MS, MBA, FACG
    Describe the optimal approach to diagnosing and managing focal liver lesions.
  • Approach to Work-Up of Abnormal Liver Tests
    Stanley M. Cohen, MD, FACG
    Recognize and apply a rational and cost-effective approach to the evaluation of abnormal liver tests.
  • Drug-Induced Liver Injury
    Haripriya Maddur, MD
    Identify cases of drug-induced liver injury and discuss best practices for their management.

Symposium 2B: C. difficile Controversies
Moderator: Paul Feuerstadt, MD, FACG

  • Fecal Transplants for C. difficile in 2022: Are We There Yet?
    Paul Feuerstadt, MD, FACG
    Summarize the evolving landscape of fecal microbiota transplantation and the future therapeutic indications for this adjunctive therapy in patients with C. difficile infection.
  • IBD and C. diff:  Treat One, the Other, or Both?
    Carl V. Crawford, MD
    Demonstrate strategies to successfully treat acute C. difficile infection and underlying IBD.
  • Where do Antimicrobials and Bezlotoxumab Fit in 2022?
    Jessica R. Allegretti, MD, MPH, FACG
    Understand best practice guidelines for medical management of C. difficile infection.

Symposium 2C: Live From Charlotte! The 10th Annual Endoscopy Video Forum

Moderators: Seth A. Gross, MD, FACG and Vivek Kaul, MD, FACG
Judges: Jodie A. Barkin, MD; Rabia A. de Latour, MD; Alexandra Guillaume, MD; Immanuel K. H. Ho, MD, FACG; Laith H. Jamil, MD, FACG; and Kenneth J. Vega, MD, FACG
Demonstrate interesting endoscopic findings and techniques encountered in daily clinical practice.
6:00 pm ACG’s Annual Business Meeting
All Members and Fellows of ACG are invited.
6:30 pm Annual Scientific Meeting Adjourns for the Day
View Tuesday Agenda